Startup Cellares adds $255M as investors pour cash into cell therapy production
BioPharma
Source: biopharmadive.com
📰 Elevate Bio News
Elevate Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Elevate Bio. Real-time updates on events, politics, business and more.
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Fulcrum Therapeutics Fourth Quarter and Full Year 2022 Earnings Conference Call. As a reminder, this conference is being recorded.
Source: insidermonkey.com
"Risky Business" How Cell Gene Therapies Are Upending Partnership Models
This article is the final installment of a three-part series examining how advanced therapy scientific and quality expectations are impacting...
Katy Spink Anna Rose Welch Access Partnership Program Novel Partnership Outsourcing Structures Louis Garguilo Outsourced Pharma
Source: lifescienceleader.com
What Trends And Innovations Are Biopharma Manufacturing Execs Watching
Five biopharmaceutical manufacturing execs share the trends and innovations they are paying closest attention to and why.

Jason Burdette Bioleslie Wolfe Michael Paglia Leslie Wolfe Rubius Therapeuticsbryan Gillis Paratek Pharma
Source: lifescienceleader.com